The increased risk of GIC was related to an increased probability of CRC detection (HR 4.4, 95% CI 1.1–17.7) and CRC-related death (HR 8.8, 95% CI 1.6–48.5) in patients with an abnormal CEA concentration. Here, CEACAM5 is linked to colorectal carcinoma.